| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |